"80631-105-02" National Drug Code (NDC)

Novavax Covid-19 Vaccine, Adjuvanted 2 VIAL, MULTI-DOSE in 1 CARTON (80631-105-02) / 2.5 mL in 1 VIAL, MULTI-DOSE (80631-105-01)
(Novavax, Inc.)

NDC Code80631-105-02
Package Description2 VIAL, MULTI-DOSE in 1 CARTON (80631-105-02) / 2.5 mL in 1 VIAL, MULTI-DOSE (80631-105-01)
Product NDC80631-105
Product Type NameVACCINE
Proprietary NameNovavax Covid-19 Vaccine, Adjuvanted
Non-Proprietary NameNvx-cov2373
Dosage FormINJECTION, SUSPENSION
UsageINTRAMUSCULAR
Start Marketing Date20231003
Marketing Category NameEMERGENCY USE AUTHORIZATION
ManufacturerNovavax, Inc.
Substance NameSARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373
Strength5
Strength Unitug/.5mL

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/80631-105-02